Clinical Trial Update: Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial evaluating ustekinumab for active ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED